We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: General Surgery

Obesity and Kidney Transplantation: Weighing Risks and Outcomes from a Swiss Single-Center Study

MedXY Editorial Team•Oct 14, 2026•General Surgery
delayed graft functionKidney Transplantationobesitysurgical complications

Highlight

  • Obese kidney transplant recipients experience significantly higher rates of surgical site infections, lymphoceles, incisional hernias, and overall infections compared to non-obese recipients.
  • Delayed graft function and prolonged hospital stays are more frequent among obese recipients.
  • Despite increased early postoperative complications, long-term patient and graft survival rates are comparable between obese and non-obese recipients.
  • Obesity should not be considered a contraindication to kidney transplantation based on current evidence.

Study Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Bariatric Surgery and Risk of Obesity-Related Cancer by Age and Sex: A Comprehensive ReviewThis review synthesizes evidence from large cohort studies and meta-analyses highlighting bariatric surgery’s association with reduced risks of many obesity-related cancers, consistent across age and sex. Mechanistic insights and implOct 19, 2026Impact of Neoadjuvant versus Adjuvant Chemotherapy on Outcomes in Prepectoral Tissue Expander Breast Reconstruction After MastectomyThis study compares surgical outcomes in prepectoral tissue expander breast reconstruction following mastectomy, revealing that adjuvant chemotherapy increases major complication risks, while neoadjuvant chemotherapy and perioperative leukoOct 18, 2026PREBOTPilot Trial: Botulinum Toxin Injection Into the Sphincter of Oddi Fails to Prevent Pancreatic Fistula After Distal PancreatectomyA randomized controlled trial showed that preoperative botulinum toxin injection into the sphincter of Oddi does not reduce the incidence of clinically relevant postoperative pancreatic fistula following distal pancreatectomy.Oct 18, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes: A Contemporary Review of Evidence and Clinical Implications
Survodutide, a dual glucagon and GLP-1 receptor agonist, demonstrates significant weight loss and glycemic improvements in adults with obesity and type 2 diabetes, offering promise as a novel therapeutic agent with favorable efficacy and sa
Oct 17, 2026
Retatrutide: A Breakthrough Triple Agonist for Obesity and Type 2 Diabetes ManagementRetatrutide, a triple agonist targeting GIP, GLP-1, and glucagon receptors, significantly reduces bodyweight and improves glycemic control in adults with obesity and type 2 diabetes, showing promising efficacy and a manageable safety profilOct 15, 2026
Elevated BMI and Open Airway Reconstruction: Disentangling the Impact on Postoperative OutcomesThis study demonstrates that elevated BMI and obesity classification do not increase the risk of complications or prolong recovery times following open airway reconstruction surgeries, guiding surgical decision-making in overweight and obesOct 8, 2026